Publisher's Synopsis
Health economics is a growing area of importance for all people involved in the delivery of health care. This timely monograph, based on the proceedings of a symposium supported by the International League Against Epilepsy (ILAE), represents the first generally available guide to cost-benefit considerations as applied to the use of anti-epileptic drugs and epilepsy surgery. Drawing on international experience, the ethical, humanitarian and economic aspects of treatment are addressed with the aim of tempering economic dogma with social needs, so as to ensure the better attainment of the goals of epilepsy care. While primarily aimed at managers and decision-makers in the healthcare industry, epileptologists will find much thought-provoking material presented in the book.
